Market Size and Growth Outlook

Argentina Interventional Peripheral Devices Market Forecast 2025 to 2035: Trends, Drivers, and Future Outlook

Size, byProduct, 2024 - 2032{USD Million}

CAGR: 3.50%

The Argentina interventional peripheral devices market was valued at USD 61.92 million in 2024 and is expected to expand at a CAGR of 3.5% from 2025 to 2035. request a free sample copy

This growth is largely driven by the increasing incidence of Peripheral Arterial Diseases (PAD), fueled by aging demographics and rising cases of chronic conditions like diabetes and hypertension. As healthcare providers increasingly favor minimally invasive interventions, there’s a growing preference for devices such as angioplasty balloons, catheters, and stents that support faster recovery and shorter hospital stays.

Evolving Healthcare Infrastructure
Argentina's private healthcare sector continues to modernize, providing greater access to advanced technologies. Private medical institutions are investing in high-precision interventional systems to raise standards of care. Simultaneously, global medtech companies are entering the local market through collaborations and distribution agreements, improving access to high-end, internationally approved devices. This influx of innovation is supported by increased clinical training, enabling professionals to effectively deploy these advanced peripheral interventions.

Growing Demand Due to Rising PAD Cases
The prevalence of PAD is rising in Argentina, closely linked to an aging population and lifestyle risk factors such as smoking, lack of physical activity, and unmanaged diabetes. As awareness of early diagnosis and interventional treatments improves, healthcare providers are seeing an increase in procedural volumes. This growing demand underscores the importance of interventional devices that can restore arterial blood flow and enhance patient outcomes.

Report Scope

Demographic Shift and Vascular Health Burden
Argentina’s aging population is playing a significant role in shaping market dynamics. According to the Pan American Health Organization, individuals aged 65 and older represented 12.4% of the country’s population in 2024—a significant increase from 9.6% in 2000. This demographic transformation is directly correlated with the rise in vascular conditions like PAD and deep vein thrombosis (DVT), both of which require device-based interventional treatment. As the elderly population continues to grow, so does the demand for specialized devices like thrombectomy tools, catheters, and peripheral stents.

Innovation and Technological Advancement
Technological progress is another cornerstone of the market's evolution. Innovations such as drug-eluting balloons, next-gen catheters, and bioresorbable stents offer reduced invasiveness and better clinical outcomes. These technologies have captured the attention of both practitioners and patients by offering faster recovery times and safer procedures. Their expanding presence in clinical settings is a key driver for future growth in the interventional peripheral devices segment in Argentina.

Argentina Interventional Peripheral Devices Market Size (2024–2035)

Base Year (2024)USD 61.92 Million
CAGR (2025–2035)3.5%

Key Players in the Market

• Medtronic Plc
  

• Abbott Laboratories
  

• Boston Scientific Corporation
  

• Becton, Dickinson and Company (BD)
  

• Terumo Corporation
  

• Cordis (Cardinal Health)
  

• Cook Medical
  

• Biotronik SE & Co. KG
  

• Philips Healthcare
  

• Merit Medical Systems

Argentina Interventional Peripheral Devices Market Segmentation

By Product Type

• Angioplasty Balloons
   

• Stents (bare-metal, drug-eluting, bioresorbable)
   

• Catheters
   

• Thrombectomy Devices
   

• Guidewires and Accessories
   

By Application

• Peripheral Artery Disease (PAD)
   

• Deep Vein Thrombosis (DVT)
   

• Chronic Venous Insufficiency
   

• Others
   

By End-User

• Hospitals
   

• Ambulatory Surgical Centers
   

• Specialty Clinics